Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This research study seeks to gain new knowledge about the addition of a carefully targeted
"boost" dose of radiation as a possible treatment for recurrent or metastatic head or neck
cancer. The name of the study intervention involved in this study is stereotactic body
radiotherapy, which is a way of delivering radiation in a more precisely targeted way and
with a higher dose than conventional radiotherapy.